|

Risperidone 1 MG Clinical Trials

3 actively recruiting trials

Also known as: MAR-Risperidone, Risperdal, Risperidone

Pipeline

Phase 1: 1Phase 2: 2

Top Sponsors

  • Centre for Addiction and Mental Health2
  • Medical University of Vienna1

Indications

  • Depression3
  • Treatment-resistant Depression2
  • Anhedonia1
  • Depression - Major Depressive Disorder1

Other3 trials

Does Psilocybin Require Psychedelic Effects to Treat Depression?
Phase 2
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Phase 1
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.